The randomized, double-blind, placebo-controlled MODEL trial (ClinicalTrials.gov Identifier: NCT05516992) evaluated the safety and efficacy of SB-01 in 417 adults with CLBP and related disability due ...

Doctors have urged the public to avoid smoking not only to reduce the risk of spinal problems but also to improve overall ...

Spine BioPharma's randomised Phase III MODEL trial assessing the transforming growth factor beta (TGF-β) antagonist, SB-01, ...

Doctors at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS) here have warned ...

Disc herniation cases are rising. It causes back pain due to disc damage. Symptoms include numbness, weakness, and lower back ...

Smoking linked to increased risk of slipped discs. NEIGRIHMS performs successful spinal surgery. Public advised to avoid ...

Dr. Carrie Jose, in her latest Health and Wellness column, explains why y your back pain isn’t going away even after rest, PT ...

MIAMI, July 29, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, ...

Vertex already has FDA approval for NaV1.8 inhibitor Journavx (suzetrigine) in acute pain, with late-stage trials on the go ...

How long does a back injury take to heal? Learn about recovery times, injury severity grades, and when footballers could return to action. Back injuries are among the most disruptive setbacks a ...